首页> 美国卫生研究院文献>British Journal of Experimental Pathology >The specificity of nephritogenic antibodies. V. Glomerular localization of anti-GP 330 and anti-GP 90 antibodies present in passive Heymann serum.
【2h】

The specificity of nephritogenic antibodies. V. Glomerular localization of anti-GP 330 and anti-GP 90 antibodies present in passive Heymann serum.

机译:肾生成抗体的特异性。 V.存在于被动Heymann血清中的抗GP 330和抗GP 90抗体的肾小球定位。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Administration in the rat of rabbit antibodies directed against rat tubular brushborder antigens (FXIA) leads to membranous glomerulopathy (HICN) associated with glomerular immune complexes (ICXS). These anti-FXIA antibodies (Abs) contain two major specificities, anti-GP 330 and anti-GP 90. The contribution of each specificity to the localization of anti-FXIA Abs was studied by direct immunofluorescence. Perfusion studies, under conditions which avoid ischaemia, confirmed that in this system glomerular localization of anti-FXIA Abs depends only on anti-GP 90 Abs, and the failure of anti-GP 330 Abs to localize after perfusion could not be attributed to ischaemia. In contrast, intravenous (i.v.) injection of anti-GP 330 Abs results in granular deposits of rabbit IgG, similar to those observed using anti-FXIA Abs. Injection i.v. of anti-GP 90 Abs results only in (faint) linear deposits. Using alternating and combined perfusion studies with these Abs, it is shown that anti-GP 90 Abs do not influence localization of anti-GP 330 Abs. In addition, systemic administration of anti-GP 90 Abs combined with perfusion of anti-GP 330 Abs does not facilitate localization of anti-GP 330 Abs. Although directly after i.v. injection of anti-FXIA Abs some anti-GP 90 Abs probably localize in the glomerular capillary wall, our results exclude a dominant or ancillary role for anti-GP 90 Abs in the formation of glomerular Icxs in HICN.
机译:在大鼠中施用针对大鼠肾小管刷毛抗原(FXIA)的兔抗体会导致与肾小球免疫复合物(ICXS)相关的膜性肾小球病(HICN)。这些抗FXIA抗体(Abs)包含两个主要特异性,即抗GP 330和抗GP90。通过直接免疫荧光研究了每种特异性对抗FXIA Abs定位的贡献。在避免局部缺血的条件下进行的灌注研究证实,在该系统中,抗FXIA Abs的肾小球定位仅取决于抗GP 90 Abs,并且抗GP 330 Abs在灌注后未能定位的现象不能归因于局部缺血。相反,静脉内(i.v.)注射抗GP 330 Abs导致兔IgG颗粒状沉积,类似于使用抗FXIA Abs观察到的沉积。静脉注射抗GP 90 Abs仅导致(微弱)线性沉积。使用这些抗体的交替和组合灌注研究显示,抗GP 90 Abs不会影响抗GP 330 Abs的定位。另外,抗GP 90 Abs的全身给药与抗GP 330 Abs的灌注结合并不能促进抗GP 330 Abs的定位。虽然直接在i.v.之后注射抗FXIA Abs一些抗GP 90 Abs可能位于肾小球毛细血管壁,我们的研究结果排除了抗GP 90 Abs在HICN肾小球Icx形成中的主导作用或辅助作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号